The emergency phase of COVID-19 is over, but the virus continues to spread widely across the globe and endanger people's lives, particularly those who are older, have chronic diseases, are immunocompromised or pregnant.
Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide.
Check your COVID-19 vaccination status and consult with your healthcare provider for any needed doses.
COVID-19 vaccines are safe.
Strict precautions are in place to help ensure the safety of all COVID-19 vaccines.
Before receiving validation from WHO and national regulatory agencies, COVID-19 vaccines were subject to rigorous testing in clinical trials to prove that they meet internationally agreed benchmarks for safety and efficacy.
Unprecedented scientific collaborations, extensive prior research and substantial public funding enabled swift COVID-19 vaccine development to be completed in record time - while maintaining high safety standards. New versions of the vaccine are being developed as the COVID-19 virus continues to circulate and change.
Since 2021, more than 13 billion COVID-19 vaccine doses have been administered globally. As with all vaccines, WHO and regulatory authorities continuously monitor the use of COVID-19 vaccines to identify and respond to any safety issues that might arise. Serious reactions to COVID-19 vaccines are extremely rare. Through this process, we establish that COVID-19 vaccines remain safe worldwide.
Read more on the safety of COVID-19 vaccines:
In September 2024, WHO's Strategic Advisory Group on Immunization (SAGE) reaffirmed the validity of its recommendations on COVID-19 vaccination and the importance of revaccination for groups at higher risk of severe disease and death (older adults, people iwht comorbidities, immunocompromised individuals and pregnant persons). Revaccination of health workers is also recommended.
The table below outlines the updated recommendations based on a person’s (1) vaccination history and (2) age and health condition.
Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers.
A single dose during pregnancy is recommended, regardless of prior vaccination. Read more: COVID-19 Q&A: Pregnancy, childbirth and the postnatal period.
It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine.
Contact your healthcare provider if you are worried about any of the side effects that you are experiencing.
If you do get COVID-19 after vaccination, you are more likely to have mild or no symptoms than if you hadn’t been vaccinated.
For people at a high risk of getting severe COVID-19, a dose of any available vaccine is more beneficial than delaying vaccination.
Many COVID-19 manufacturers have developed or are in the process of developing updated vaccines to target the current circulating variants. When such vaccines become available, those eligible for revaccination could consider such vaccines.
Link nội dung: https://giaitri.edu.vn/vacvin-a72814.html